1. Home
  2. TLF vs LPCN Comparison

TLF vs LPCN Comparison

Compare TLF & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tandy Leather Factory Inc.

TLF

Tandy Leather Factory Inc.

HOLD

Current Price

$2.30

Market Cap

18.2M

ML Signal

HOLD

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$2.30

Market Cap

19.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLF
LPCN
Founded
1980
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.2M
19.1M
IPO Year
2006
2011

Fundamental Metrics

Financial Performance
Metric
TLF
LPCN
Price
$2.30
$2.30
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
49.4K
94.6K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
32.05%
N/A
EPS Growth
1122.22
46.18
EPS
0.03
N/A
Revenue
$76,324,000.00
$1,976,677.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$92.00
P/E Ratio
$76.67
N/A
Revenue Growth
2.60
N/A
52 Week Low
$2.20
$1.81
52 Week High
$3.78
$12.37

Technical Indicators

Market Signals
Indicator
TLF
LPCN
Relative Strength Index (RSI) 45.70 46.51
Support Level $2.25 $2.16
Resistance Level $2.45 $2.46
Average True Range (ATR) 0.07 0.13
MACD -0.01 0.05
Stochastic Oscillator 29.41 79.55

Price Performance

Historical Comparison
TLF
LPCN

About TLF Tandy Leather Factory Inc.

Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, and Canada. it generates the highest revenue from the United States.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: